Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Raf-1 is not required for megakaryocytopoiesis or TPO-induced ERK phosphorylation.

Kamata T, Pritchard CA, Leavitt AD.

Blood. 2004 Apr 1;103(7):2568-70. Epub 2003 Oct 23.

2.

An overview of thrombopoietin: with a historical perspective.

Levin J.

C R Acad Sci III. 1995 May;318(5):609-18. Review.

PMID:
7671007
3.

[Positive and negative regulation of megakaryocytopoiesis].

Bellucci S, Han ZC, Caen JP.

C R Seances Soc Biol Fil. 1996;190(5-6):515-32. Review. French.

PMID:
9074717
4.

The enigmatic megakaryocyte gradually reveals its secrets.

Kaushansky K.

Bioessays. 1999 Apr;21(4):353-60. Review.

PMID:
10377897
5.

Regulation of megakaryocytopoiesis and platelet production: lessons from animal models.

de Sauvage FJ, Villeval JL, Shivdasani RA.

J Lab Clin Med. 1998 Jun;131(6):496-501. Review. No abstract available.

PMID:
9626984
6.

A historical perspective and cellular regulation of megakaryocytopoiesis.

Baatout S.

Haematologia (Budap). 1998;29(2):67-79. Review.

PMID:
9728799
7.

[Cloning of thrombopoietin and its physiologic role in megakaryocytopoiesis and thrombopoiesis].

Miyazaki H.

Rinsho Ketsueki. 1996 Jan;37(1):1-6. Review. Japanese. No abstract available.

PMID:
8683861
8.

Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis.

Eaton DL, de Sauvage FJ.

Exp Hematol. 1997 Jan;25(1):1-7. Review. No abstract available.

PMID:
8989900
9.

Thrombopoietin.

Kaushansky K.

N Engl J Med. 1998 Sep 10;339(11):746-54. Review. No abstract available.

PMID:
9731092
10.

Systems biology of megakaryocytes.

Kaushansky A, Kaushansky K.

Adv Exp Med Biol. 2014;844:59-84. doi: 10.1007/978-1-4939-2095-2_4. Review.

PMID:
25480637
11.

[Effects of heparin on megakaryocytopoiesis. From fundamental data to clinical applications].

Bellucci S, Han ZC, Caen J.

Ann Med Interne (Paris). 1997;148(2):150-3. Review. French.

PMID:
9238440
12.

Megakaryocyte structure and function.

Cramer EM.

Curr Opin Hematol. 1999 Sep;6(5):354-61. Review. Erratum in: Curr Opin Hematol 1999 Nov;6(6):446.

PMID:
10468153
13.

[Effect of 5-hydroxtryptamine on megakaryocytopoiesis--review].

Cheng YS, Liu YS, Yang M.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Apr;14(2):403-7. Review. Chinese.

PMID:
16638226
14.

Thrombopoietin: its role in platelet disorders and as a new drug in clinical medicine.

von dem Borne AE, Folman C, Linthorst GE, Porcelijn L, van den Oudenrijn S, van der Schoot E, de Haas M.

Baillieres Clin Haematol. 1998 Jun;11(2):427-45. Review. No abstract available.

PMID:
10097818
15.

Thrombopoietin.

Ebbe S.

Blood. 1974 Oct;44(4):605-8. Review. No abstract available.

16.

Thrombopoietin expression and plasma concentrations in chronic myeloproliferative disorders.

Tefferi A.

Leuk Res. 2003 Feb;27(2):121-3. Review. No abstract available.

PMID:
12526917
17.

[Paris-Trousseau thrombocytopenia: a new entity and a model for understanding megakaryocytopoiesis].

Favier R.

Pathol Biol (Paris). 1997 Nov;45(9):693-6. Review. French. No abstract available.

PMID:
9538465
18.

Regulation of megakaryocytopoiesis.

Hoffman R.

Blood. 1989 Sep;74(4):1196-212. Review. No abstract available.

19.

[Regulation of megakaryocytopoiesis].

Podolak-Dawidziak M.

Acta Haematol Pol. 1994;25(2 Suppl 1):62-5. Review. Polish. No abstract available.

PMID:
8067209
20.

[Megakaryocytopoiesis and its regulating mechanisms].

Rolović Z.

Lijec Vjesn. 1988 Dec;110(12):428-36. Review. Croatian. No abstract available.

PMID:
3073288

Supplemental Content

Support Center